R. Daubney, J. R. Hudson, and P. C. Garnham, Enzootic hepatitis or rift valley fever. An undescribed virus disease of sheep cattle and man from east Africa, J Pathol Bacteriol, vol.34, pp.545-79, 1931.

L. M. Tantely, S. Boyer, and D. Fontenille, A review of mosquitoes associated with Rift Valley fever virus in Madagascar, Am J Trop Med Hyg, vol.92, pp.722-731, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01291994

F. Monaco, C. Pinoni, G. M. Cosseddu, S. Khaiseb, P. Calistri et al., Rift Valley fever in Namibia, Emerging Infect Dis, vol.19, pp.2025-2032, 2010.

A. Hartman, Rift Valley Fever, Clin Lab Med, vol.37, pp.285-301, 2017.

D. Wright, J. Kortekaas, T. A. Bowden, and G. M. Warimwe, Rift Valley fever: biology and epidemiology, J Gen Virol, vol.100, pp.1187-99, 2019.

, Biosafety in Microbiological and Biomedical Laboratories (BMBL), 5th Edn. CDC Laboratory Portal, Centers for Disease Control (CDC), 2018.

J. Martinet, H. Ferté, A. Failloux, F. Schaffner, and J. Depaquit, Mosquitoes of North-Western Europe as potential vectors of arboviruses: a review, Viruses, vol.11, p.1059, 2019.
URL : https://hal.archives-ouvertes.fr/pasteur-02388933

M. Pepin, M. Bouloy, B. H. Bird, A. Kemp, and J. Paweska, Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention, Vet Res, vol.41, p.61, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00903196

C. Tong, E. Javelle, G. Grard, A. Dia, C. Lacrosse et al., Tracking Rift Valley fever: from Mali to Europe and other countries, Eurosurveillance, vol.24, p.1800213, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02263770

V. Chevalier, Relevance of Rift Valley fever to public health in the European Union, Clin Microbiol Infect, vol.19, pp.705-713, 2013.

J. Liu, Y. Sun, W. Shi, S. Tan, Y. Pan et al., The first imported case of Rift Valley fever in China reveals a genetic reassortment of different viral lineages, Emerg Microbes Infect, vol.6, p.4, 2017.

S. Wiwanitkit, Emerging Rift Valley fever in China: what should be known?, Asian Pac J Trop Biomed, vol.6, issue.9, pp.727-736, 2016.

S. Lumley, L. M. Hernández-triana, D. L. Horton, M. Fernández-de-marco, J. M. Medlock et al., Competence of mosquitoes native to the United Kingdom to support replication and transmission of Rift Valley fever virus, Parasite Vectors, vol.11, p.308, 2018.

D. M. Hartley, J. L. Rinderknecht, T. L. Nipp, N. P. Clarke, and G. D. Snowder, National Center for Foreign Animal and Zoonotic Disease Defense Advisory Group on Rift Valley Fever. Potential effects of Rift Valley fever in the United States, Emerging Infect Dis, vol.17, p.1, 2011.

D. A. Hartman, L. M. Rice, J. Demaria, E. M. Borland, N. A. Bergren et al., Entomological risk factors for potential transmission of Rift Valley fever virus around concentrations of livestock in Colorado, Transbound Emerg Dis, vol.66, pp.1709-1726, 2019.

O. Dar, S. Mcintyre, S. Hogarth, and D. Heymann, Rift Valley fever and a new paradigm of research and development for zoonotic disease control, Emerging Infect Dis, vol.19, pp.189-93, 2013.

L. W. Laughlin, J. M. Meegan, L. J. Strausbaugh, D. M. Morens, and R. H. Watten, Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness, Trans R Soc Trop Med Hyg, vol.73, pp.630-633, 1979.

K. Ahmad, More deaths from Rift Valley fever in Saudi Arabia and Yemen, Lancet, vol.356, p.1422, 2000.

M. Mohamed, F. Mosha, J. Mghamba, S. R. Zaki, W. Shieh et al., Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, Am J Trop Med Hyg, vol.83, pp.22-29, 2007.

P. Bourée, Rift Valley Fever: new outbreak in Mayotte, Bull Soc Pathol Exot, vol.112, pp.153-158, 2019.

Y. E. Himeidan, E. J. Kweka, M. M. Mahgoub, E. A. El-rayah, and J. O. Ouma, Recent outbreaks of Rift Valley Fever in East Africa and the Middle East. Front Public Health, vol.2, p.169, 2014.

D. Moher, L. Shamseer, M. Clarke, D. Ghersi, A. Liberati et al., Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P), statement. Syst Rev, p.4, 2015.

, World Health Organization (WHO), 2019.

, Outbreak Summaries Rift Valley Fever, Centers for Disease Control, 2019.

M. O. Nanyingi, P. Munyua, S. G. Kiama, G. M. Muchemi, S. M. Thumbi et al., A systematic review of Rift Valley Fever epidemiology 1931-2014, Infect Ecol Epidemiol, vol.5, p.28024, 2015.

J. Morvan, J. F. Saluzzo, D. Fontenille, P. E. Rollin, and P. Coulanges, Rift Valley fever on the east coast of Madagascar, Res Virol, vol.142, pp.475-82, 1991.

R. Métras, L. Cavalerie, L. Dommergues, P. Mérot, W. J. Edmunds et al., The Epidemiology of Rift Valley Fever in Mayotte: insights and perspectives from 11 years of data, PLoS Negl Trop Dis, vol.10, issue.6, p.4783, 2016.

D. Sissoko, C. Giry, P. Gabrie, A. Tarantola, F. Pettinelli et al., Rift Valley fever, Mayotte, Emerging Infect Dis, vol.15, pp.568-70, 2007.

T. Lernout, E. Cardinale, M. Jego, P. Desprès, L. Collet et al., Rift valley fever in humans and animals in Mayotte, an endemic situation?, PLoS ONE, vol.8, p.74192, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00972561

. Linfo, Fièvre de la Vallée du Rift: 141 cas humains signalés à Mayotte, 2019.

H. Gaff, D. Hartley, and N. Leahy, An epidemiological model of Rift Valley Fever, Electron J Diff Eq, vol.115, pp.1-12, 2007.

T. Niu, H. D. Gaff, Y. E. Papelis, and D. M. Hartley, An epidemiological model of Rift Valley fever with spatial dynamics, Comput Math Methods Med, p.138757, 2012.

J. Li, D. Blakeley, and R. J. Smith, The failure of R0, Comput Math Methods Med, 2011.

T. Ikegami and S. Makino, The pathogenesis of Rift Valley Fever, Viruses, vol.3, pp.493-519, 2011.

M. Pépin, avec la participation de la CIRE Réunion-Mayotte et l'Institut de Veille Sanitaire (InVS). Rift Valley fever, Med Mal Infect, vol.41, pp.322-331, 2011.

A. , E. Baz, L. M. El-tayeb, E. M. Omar, H. Ossman et al., Rift Valley Fever virus infections in Egypt: pathological and virological findings in man, Trans R Soc Trop Med Hyg, vol.72, pp.392-398, 1978.

A. L. Siam, J. M. Meegan, and K. F. Gharbawi, Rift Valley fever ocular manifestations: observations during the 1977 epidemic in Egypt, Br J Ophthalmol, vol.64, pp.366-74, 1980.

, Rwanda Biomedical Centre. GUIDELINES ON RIFT VALLEY FEVER Revised, vol.22, 2018.

T. A. Madani, Y. Y. Al-mazrou, A. , M. H. Mishkhas, A. A. Al-rabeah et al., Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics, Clin Infect Dis, vol.37, pp.1084-92, 2003.

, Rift Valley fever outbreak-Kenya, Centers for Disease Control and Prevention (CDC), vol.56, pp.73-79, 2006.

, Update: Outbreak of Rift Valley Fever Saudi Arabia, Centers for Disease Control (CDC), 2000.

S. S. Kahlon, C. J. Peters, J. Leduc, E. M. Muchiri, S. Muiruri et al., Severe Rift Valley fever may present with a characteristic clinical syndrome, Am J Trop Med Hyg, vol.82, pp.371-376, 2010.

D. J. Van-velden, J. D. Meyer, J. Olivier, J. H. Gear, and B. Mcintosh, Rift Valley fever affecting humans in South Africa: a clinicopathological study, S Afr Med J, vol.51, pp.867-71, 1977.

M. B. Boushab, M. Savadogo, M. S. Sow, F. Z. Fall-malick, and M. Seydi, Severe hemorrhagic form of Rift Valley Fever in Mauritania, Bull Soc Pathol Exot, vol.108, pp.102-108, 2015.

R. A. Rakotoarivelo, R. Andrianasolo, S. H. Razafimahefa, R. Razafimbelo, N. S. Randria et al., Severe presentations of Rift Valley Fever in Madagascar, Med Mal Infect, vol.41, pp.318-339, 2011.

M. Al-hazmi, E. A. Ayoola, M. Abdurahman, S. Banzal, J. Ashraf et al., Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans, Clin Infect Dis, vol.36, pp.245-52, 2003.

L. Nderitu, J. S. Lee, J. Omolo, S. Omulo, M. L. O'guinn et al., Sequential Rift Valley fever outbreaks in eastern Africa caused by multiple lineages of the virus, J Infect Dis, vol.203, pp.655-65, 2011.

M. Baba, D. K. Masiga, R. Sang, and J. Villinger, Has Rift Valley fever virus evolved with increasing severity in human populations in East Africa?, Emerg Microbes Infect, vol.5, p.58, 2016.

J. C. Morrill, T. Ikegami, N. Yoshikawa-iwata, N. Lokugamage, S. Won et al., Rapid accumulation of virulent rift valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA, PLoS ONE, vol.5, p.9986, 2010.

B. H. Bird, M. L. Khristova, P. E. Rollin, T. G. Ksiazek, and N. St, Complete genome analysis of 33 ecologically and biologically diverse Rift Valley Fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry, J Virol, vol.81, pp.2805-2821, 2007.

B. H. Bird and A. K. Mcelroy, Rift Valley fever virus: unanswered questions, Antiviral Res, vol.132, pp.274-80, 2016.

A. D. Labeaud, S. Pfeil, S. Muiruri, S. Dahir, L. J. Sutherland et al., Factors associated with severe human Rift Valley fever in Sangailu, PLoS Negl Trop Dis, vol.9, p.3548, 2015.

M. K. Njenga, J. Paweska, R. Wanjala, C. Y. Rao, M. Weiner et al., Using a field quantitative real-time PCR test to rapidly identify highly viremic rift valley fever cases, J Clin Microbiol, vol.47, pp.1166-71, 2009.

A. G. Hise, Z. Traylor, N. B. Hall, L. J. Sutherland, S. Dahir et al., Association of symptoms and severity of rift valley fever with genetic polymorphisms in human innate immune pathways, PLoS Negl Trop Dis, vol.9, p.3584, 2015.

J. T. Paweska, Rift Valley Fever, Rev Sci Tech Off Int Epiz, vol.34, pp.375-89, 2015.
URL : https://hal.archives-ouvertes.fr/hal-00903196

D. R. Smith, K. E. Steele, J. Shamblin, A. Honko, J. Johnson et al., The pathogenesis of Rift Valley fever virus in the mouse model, Virology, vol.407, pp.256-67, 2010.

A. E. Ayoola, M. H. Al-hazmi, N. T. Michail, A. Aderoju, M. M. Hafez et al., Liver involvement in patients with moderately severe rift valley fever, The American Journal of Gastroenterology, vol.98, p.92, 2003.

M. A. Shraim, R. Eid, K. Radad, and N. Saeed, Ultrastructural pathology of human liver in Rift Valley fever, BMJ Case Rep, 2016.

W. Shieh, C. D. Paddock, E. Lederman, C. Y. Rao, L. H. Gould et al., Pathologic studies on suspect animal and human cases of Rift Valley fever from an outbreak in Eastern Africa, Am J Trop Med Hyg, vol.83, pp.38-42, 2006.

B. M. Boushab, F. Z. Fall-malick, O. Baba, S. , O. Salem et al., Severe human illness caused by Rift Valley Fever Virus in Mauritania, Open Forum Infect Dis, vol.3, 0200.

B. Philippe, A. Jouan, O. Riou, I. Coulibaly, B. Leguenno et al., Hemorrhagic forms of Rift Valley fever in Mauritania, Bull Soc Pathol Exot, vol.82, pp.611-620, 1989.

L. J. Strausbaugh, L. W. Laughlin, J. M. Meegan, and R. H. Watten, Clinical studies on Rift Valley fever, Part I: acute febrile and hemorrhagic-like diseases, J Egypt Public Health Assoc, vol.53, pp.181-183, 1978.

F. Adam, A. Jouan, O. Riou, P. B. Coulibaly, I. Berlioz et al., Development of a clinical and biological scoring system for the prognosis of Rift Valley fever, Bull Soc Pathol Exot, vol.82, pp.628-664, 1989.

A. Jouan, B. Philippe, O. Riou, I. Coulibaly, B. Leguenno et al., Mild clinical forms of Rift Valley fever during the epidemic in Mauritania, Bull Soc Pathol Exot, vol.82, pp.620-627, 1989.

T. S. Al-khuwaitir, A. M. Al-moghairi, S. M. Sherbeeni, and A. As, Rift Valley fever hepatitis complicated by disseminated intravascular coagulation and hepatorenal syndrome, Saudi Med J, vol.25, pp.528-559, 2004.

A. S. Anyangu, L. H. Gould, S. K. Sharif, P. M. Nguku, J. O. Omolo et al., Risk factors for severe Rift Valley fever infection in Kenya, Am J Trop Med Hyg, vol.83, pp.14-21, 2007.

M. Salem, S. Baba, F. Z. Fall-malick, B. M. Boushab, S. M. Ghaber et al., Severe hemorrhagic forms of Rift Valley fever: about 5 cases, Pan Afr Med J, vol.24, p.73, 2016.

D. St-maurice, A. Harmon, J. Nyakarahuka, L. Balinandi, S. Tumusiime et al., Rift valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations, PLoS Negl Trop Dis, vol.12, p.6460, 2018.

A. A. Alrajhi, A. Al-semari, and J. Al-watban, Rift Valley fever encephalitis, Emerging Infect Dis, vol.10, pp.554-559, 2004.

O. Riou, P. B. Jouan, A. Coulibaly, I. Mondo, M. Digoutte et al., Neurologic and neurosensory forms of Rift Valley fever in Mauritania, Bull Soc Pathol Exot, vol.82, pp.605-615, 1989.

S. A. Maar, R. Swanepoel, and M. Gelfand, Rift Valley fever encephalitis. A description of a case, Cent Afr J Med, vol.25, pp.8-11, 1979.

L. W. Laughlin, N. I. Girgis, J. M. Meegan, L. J. Strausbaugh, M. W. Yassin et al., Clinical studies on Rift Valley fever. Part 2: Ophthalmologic and central nervous system complications, J Egypt Public Health Assoc, vol.53, pp.183-187, 1978.

F. Haneche, I. Leparc-goffart, F. Simon, M. Hentzien, V. Martinez-pourcher et al., Rift Valley fever in kidney transplant recipient returning from Mali with viral RNA detected in semen up to four months from symptom onset, France, autumn 2015. Eurosurveillance, 2016.

C. Reed, K. Lin, C. Wilhelmsen, B. Friedrich, A. Nalca et al., Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development, PLoS Negl Trop Dis, vol.7, p.2156, 2013.

A. L. Hartman, D. S. Powell, L. M. Bethel, A. L. Caroline, R. J. Schmid et al., Aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets, J Virol, vol.88, pp.2235-2280, 2014.

C. A. Wiley, N. Bhardwaj, T. M. Ross, and S. J. Bissel, Emerging infections of CNS: avian influenza A virus, Rift Valley Fever Virus and human parechovirus, Brain Pathol, vol.25, pp.634-50, 2015.

J. R. Albe, D. A. Boyles, A. W. Walters, M. R. Kujawa, C. M. Mcmillen et al., Neutrophil and macrophage influx into the central nervous system are inflammatory components of lethal Rift Valley fever encephalitis in rats, PLoS Pathog, vol.15, p.1007833, 2019.

E. R. Wonderlich, A. L. Caroline, C. M. Mcmillen, A. W. Walters, D. S. Reed et al., Peripheral blood biomarkers of disease outcome in a monkey Model of Rift Valley Fever encephalitis, J Virol, vol.92, pp.1662-1679, 2018.

A. W. Walters, M. R. Kujawa, J. R. Albe, D. S. Reed, W. B. Klimstra et al., Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats, Virology, vol.526, pp.173-182, 2019.

M. El-imam, E. Sabiq, M. Omran, M. Abdalkareem, A. et al., Acute renal failure associated with the Rift Valley fever: a single center study, Saudi J Kidney Dis Transpl, vol.20, pp.1047-52, 2009.

I. Freed, Rift valley fever in man, complicated by retinal changes and loss of vision, S Afr Med J, vol.25, pp.930-932, 1951.

L. Schrire, Macular changes in rift valley fever, S Afr Med J, vol.25, pp.926-956, 1951.

A. Al-hazmi, A. A. Al-rajhi, E. B. Abboud, E. A. Ayoola, M. Al-hazmi et al., Ocular complications of Rift Valley fever outbreak in Saudi Arabia, Ophthalmology, vol.112, pp.313-321, 2005.

S. L. Yoser, D. J. Forster, and N. A. Rao, Systemic viral infections and their retinal and choroidal manifestations, Surv Ophthalmol, vol.37, pp.313-52, 1993.

S. Newman-gerhardt, S. Muiruri, E. Muchiri, C. J. Peters, J. Morrill et al., Potential for autoimmune pathogenesis of Rift Valley Fever virus retinitis, Am J Trop Med Hyg, vol.89, pp.495-502, 2013.

R. Ranjan and S. Ranjan, Ocular pathology: role of emerging viruses in the Asia-Pacific Region-A review, Asia-Pac J Ophthalmol, vol.3, pp.299-307, 2014.

M. Khairallah, A. Ladjimi, M. Chakroun, R. Messaoud, S. B. Yahia et al., Posterior segment manifestations of Rickettsia conorii infection, Ophthalmology, vol.111, pp.529-563, 2004.

M. Khairallah, R. Kahloun, B. Yahia, S. Jelliti, B. Messaoud et al., New infectious etiologies for posterior uveitis, Ophthalmic Res, vol.49, pp.66-72, 2013.

I. Galindo-cardiel, N. Busquets, R. Velarde, F. X. Abad, D. Solanes et al., Lymphoplasmacytic endotheliitis and anterior uveitis in sheep infected experimentally with rift valley fever virus, J Comp Pathol, vol.146, pp.40-43, 2012.

B. Niklasson, J. Liljestrand, S. Bergström, and C. J. Peters, Rift Valley fever: a sero-epidemiological survey among pregnant women in Mozambique, Epidemiol Infect, vol.99, pp.517-539, 1987.

A. Meegan, J. M. Laughlin, and L. W. , Rift Valley fever as a possible cause of human abortions, Trans R Soc Trop Med Hyg, vol.74, pp.685-691, 1980.

M. Baudin, A. M. Jumaa, H. Jomma, M. S. Karsany, G. Bucht et al., Association of Rift Valley fever virus infection with miscarriage in Sudanese women: a cross-sectional study, Lancet Glob Health, vol.4, pp.864-71, 2016.

I. Adam and M. S. Karsany, Case report: Rift Valley Fever with vertical transmission in a pregnant Sudanese woman, J Med Virol, vol.80, p.929, 2008.

H. M. Arishi, A. Y. Aqeel, A. Hazmi, and M. M. , Vertical transmission of fatal Rift Valley fever in a newborn, Ann Trop Paediatr, vol.26, pp.251-254, 2006.

C. W. Woods, A. M. Karpati, T. Grein, N. Mccarthy, P. Gaturuku et al., An outbreak of Rift Valley Fever in Northeastern Kenya, 1997-98, Emerg Infect Dis, vol.8, pp.138-182, 2002.

A. Azraqi, T. A. , E. Mekki, A. A. Mahfouz, and A. A. , Rift Valley fever among children and adolescents in southwestern Saudi Arabia, J Infect Public Health, vol.6, pp.230-235, 2013.

, Isolation precautions. Guidelines library. Infection Control, Centers for Disease Control (CDC), 2019.

N. A. Al-hamdan, A. A. Panackal, A. Bassam, T. H. Alrabea, A. et al., The risk of nosocomial transmission of Rift Valley Fever, PLoS Negl Trop Dis, vol.9, p.4314, 2015.

, Standard precautions in health care, 2007.

, Fièvre de la vallée du Rift en Afrique: aspects cliniques chez l'homme, 2019.

M. Kende, C. R. Alving, W. L. Rill, G. M. Swartz, and P. G. Canonico, Enhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus infection in mice, Antimicrob Agents Chemother, vol.27, pp.903-910, 1985.

J. W. Huggins, Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug, Rev Infect Dis, vol.11, issue.4, pp.750-61, 1989.

P. Bossi, A. Tegnell, A. Baka, F. Van-loock, J. Hendriks et al., Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses, Eurosurveillance, vol.9, pp.11-13, 2004.

D. G. Bausch, C. M. Hadi, S. H. Khan, and J. Lertora, Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever, Clin Infect Dis, vol.51, pp.1435-1476, 2010.

M. K. Islam, M. Strand, M. Saleeb, R. Svensson, P. Baranczewski et al., Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound, Sci Rep, vol.8, 1925.

D. Scharton, K. W. Bailey, Z. Vest, J. B. Westover, Y. Kumaki et al., T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment, Antiviral Res, vol.104, pp.84-92, 2014.

D. F. Smee, K. Jung, J. Westover, and B. B. Gowen, 2?-Fluoro-2?-deoxycytidine is a broad-spectrum inhibitor of bunyaviruses in vitro and in phleboviral disease mouse models, Antiviral Res, vol.160, pp.48-54, 2018.

B. Borrego, A. I. De-Ávila, E. Domingo, and A. Brun, Lethal mutagenesis of Rift Valley Fever Virus induced by favipiravir, Antimicrob Agents Chemother, vol.63, pp.669-688, 2019.

C. Atkins and A. N. Freiberg, Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection, Future Virol, vol.12, pp.651-65, 2017.

E. R. Allen, S. A. Krumm, J. Raghwani, S. Halldorsson, A. Elliott et al., A protective monoclonal antibody targets a site, vol.18, p.18

. Javelle, 19:4 ? fast, convenient online submission ? thorough peer review by experienced researchers in your field ? rapid publication on acceptance ? support for research data, including large and complex data types ? gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over, Ann Clin Microbiol Antimicrob, 2020.

, Ready to submit your research ? Choose BMC and benefit from: of vulnerability on the surface of Rift Valley Fever Virus, Cell Rep, vol.25, p.4, 2018.

J. W. Karesh, R. A. Mazzoli, and S. K. Heintz, Ocular manifestations of mosquitotransmitted diseases, Mil Med, vol.183, pp.450-458, 2018.

F. Simon, E. Javelle, A. Cabie, E. Bouquillard, O. Troisgros et al., French guidelines for the management of chikungunya (acute and persistent presentations), Med Mal Infect, vol.45, pp.243-63, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01914835

M. M. Hassan, A. Agarwal, R. M. Afridi, M. Dasilva, I. Karaca et al., The role of optical coherence tomography angiography in the management of uveitis, Int Ophthalmol Clin Fall, vol.2016, issue.56, pp.1-24, 2016.

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations